Impact of intratumoral expression levels of fluoropyrimidine-metabolizing enzymes on treatment outcomes of adjuvant S-1 therapy in gastric cancer.

PLoS One · 2015 · PMC4368508 · PMID 25793299

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

showed a trendP = 0.068so close (0.05 < p ≤ 0.1)

While the expression levels of four proteins were not significantly related to DFS ( Table 2 ), low DPD expression level (IHC score < 10 [cut-off value; median]) showed a trend towards worse 5-year DFS (78% vs. 88%; P = 0.068; Fig. 2(A) ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.